Criterium, Inc.
Clinical trials sponsored by Criterium, Inc., explained in plain language.
-
Blood test spots Cancer's return early, triggers stronger drug defense
Disease control Recruiting nowThis study is for people with a high-risk type of breast cancer who are already on standard hormone-blocking pills. It first uses a special blood test to look for tiny signs of cancer that might be returning. If the test turns positive but a scan shows no visible spread, patients…
Phase: PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo tested for Tough-to-Treat breast cancer
Disease control Recruiting nowThis study is testing whether combining three existing drugs—tucatinib, trastuzumab, and eribulin—is safe and effective for people with advanced HER2+ breast cancer that has continued to grow despite previous treatments. It will enroll about 30 adults to see if this combination c…
Phase: PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for patients out of options: testing a powerful combo against tough colon cancer
Disease control Recruiting nowThis study is for people with advanced colorectal cancer that has stopped responding to standard treatments. It aims to see if taking two oral drugs, fruquintinib and TAS-102, together works better at controlling the cancer and helping patients live longer without it getting wors…
Phase: PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC